Clinical trial
Improvement of Liver Function in Liver Cirrhosis Patients After Autologous…
NCT00420134 · Shahid Beheshti University of Medical Sciences, Other · Completed
Key facts
| NCT number | NCT00420134 |
|---|---|
| Title | Improvement of Liver Function in Liver Cirrhosis Patients After Autologous Mesenchymal Stem Cell Injection:a Phase I-II Clinical Trial |
| Official title | A Phase One/Two Clinical Trial on the Use of Autograft Mesenchymal Stem Cells Differentiated Into Progenitor of Hepatocytes for the Salvage Treatment of Patients With End-stage Liver Disease |
| Lead sponsor | Shahid Beheshti University of Medical Sciences, Other |
| Collaborators | Tarbiat Modarres University |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Liver Failure, Cirrhosis |
| Intervention type | Procedure |
| Interventions | injection of progenitor of hepatocyte drived from Mesenchymal stem cell |
| Enrollment | 30 |
| Start date | Feb 1, 2006 |
| Primary completion | May 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Jan 9, 2007 |
| Last update posted | Sep 17, 2009 |
| Countries | Iran |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: